Stock Scheduled Dividends 11/28/2018
11/29/2018 KTBA
Stock Scheduled Dividends 11/28/2018
11/29/2018 KTBA Structured Products Corp. Structured Product Pink No Information Cash Dividend 0.875
11/29/2018 FIZN First Citizens Bancshares, Inc. Common Stock Pink Current Cash Dividend 0.30
11/29/2018 EFRTF Nexus Real Estate Investment Trust Other Security Type Grey Market Cash Dividend 0.01333
11/29/2018 SBNC Southern Bancshares (N.C.), Inc. Common Stock Pink Current Cash Dividend 1.25
11/29/2018 SBNCM Southern Bancshares (N.C.), Inc. Preferred Stock Pink Current Cash Dividend 0.23
11/29/2018 SBNCN Southern Bancshares (N.C.), Inc. Preferred Stock Pink Current Cash Dividend 0.23
11/29/2018 CPKF Chesapeake Financial Shares, Inc. Common Stock OTCQB Cash Dividend 0.14
11/29/2018 SCIV Savings Bank Circleville, Ohio Common Stock Grey Market Cash Dividend 0.85
11/29/2018 FBAK First National Bank Alaska Common Stock OTCQX U.S. Premier Cash Dividend 3.20
11/29/2018 NCRRP NCR Corp. Preferred Stock Pink Current Stock Dividend/Split 1.01375
11/29/2018 ICAGY International Consolidated Airlines Group SA American Depository Receipts Pink Current Cash Dividend 0.31359
11/29/2018 FREVS First Real Estate Investment Trust of New Jersey Fund Pink Current Cash Dividend 0.05
11/29/2018 SFDL Security Federal Corp. Common Stock Pink Current Cash Dividend 0.09
11/29/2018 SLFPD Standard Life Aberdeen PLC American Depository Receipts Pink Current Cash Dividend 1.71543
11/29/2018 BLWYY Bellway Plc. American Depository Receipts Pink Current Cash Dividend 1.1888
11/29/2018 MBRRP Mobile & Birmingham Railroad Preferred Stock Grey Market Cash Dividend 2.00
11/29/2018 CESDF CES Energy Solutions Corp. Ordinary Shares Pink Current Cash Dividend 0.005
11/29/2018 CTGSP Connecticut Natural Gas Corp. Preferred Stock Pink No Information Cash Dividend 0.0625
11/29/2018 TVNB Turbotville National Bancorp, Inc. Common Stock Pink Current Cash Dividend 1.75
11/29/2018 PDER Pardee Resources Co. Common Stock Pink No Information Cash Dividend 1.80
11/29/2018 ZNCMP Zunicom, Inc. Preferred Stock Grey Market Cash Dividend 0.09
11/29/2018 TLKGY Telkom SA SOC Ltd American Depository Receipts Pink Current Cash Dividend 0.23063
11/29/2018 NFBP Newfield Bancorp, Inc. Common Stock Grey Market Stock Dividend/Split 1.03
11/29/2018 OSTKP Overstock.com, Inc. Preferred Stock Pink Current Cash Dividend 0.16
11/29/2018 KLIB Killbuck Bancshares Inc. Common Stock Pink Current Cash Dividend 2.25
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Top 5 Most Recently Viewed Articles
Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...
Continue Reading
dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...
Continue Reading
Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...
Continue Reading
Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...
Continue Reading
The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...
Continue Reading